Xeris Pharmaceuticals Stock Forecast - Naive Prediction

XERS Stock  USD 7.61  0.01  0.13%   
The Naive Prediction forecasted value of Xeris Pharmaceuticals on the next trading day is expected to be 7.96 with a mean absolute deviation of 0.28 and the sum of the absolute errors of 17.07. Xeris Stock Forecast is based on your current time horizon.
At this time the relative strength index (rsi) of Xeris Pharmaceuticals' share price is below 20 . This entails that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards.

Momentum 0

 Sell Peaked

 
Oversold
 
Overbought
The successful prediction of Xeris Pharmaceuticals' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Xeris Pharmaceuticals and does not consider all of the tangible or intangible factors available from Xeris Pharmaceuticals' fundamental data. We analyze noise-free headlines and recent hype associated with Xeris Pharmaceuticals, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting Xeris Pharmaceuticals' stock price prediction:
EPS Estimate Next Quarter
0.0333
EPS Estimate Current Year
0.063
EPS Estimate Next Year
0.3145
Wall Street Target Price
11.1429
EPS Estimate Current Quarter
0.0033
Using Xeris Pharmaceuticals hype-based prediction, you can estimate the value of Xeris Pharmaceuticals from the perspective of Xeris Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Xeris Pharmaceuticals using Xeris Pharmaceuticals' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Xeris using crowd psychology based on the activity and movement of Xeris Pharmaceuticals' stock price.

Xeris Pharmaceuticals Implied Volatility

    
  0.95  
Xeris Pharmaceuticals' implied volatility exposes the market's sentiment of Xeris Pharmaceuticals stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Xeris Pharmaceuticals' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Xeris Pharmaceuticals stock will not fluctuate a lot when Xeris Pharmaceuticals' options are near their expiration.
The Naive Prediction forecasted value of Xeris Pharmaceuticals on the next trading day is expected to be 7.96 with a mean absolute deviation of 0.28 and the sum of the absolute errors of 17.07.

Xeris Pharmaceuticals after-hype prediction price

    
  USD 7.61  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Xeris Pharmaceuticals to cross-verify your projections.
For more information on how to buy Xeris Stock please use our How to Invest in Xeris Pharmaceuticals guide.At this time, Xeris Pharmaceuticals' Inventory Turnover is comparatively stable compared to the past year. Payables Turnover is likely to gain to 15.20 in 2026, whereas Receivables Turnover is likely to drop 3.91 in 2026. . Common Stock Shares Outstanding is likely to gain to about 177.2 M in 2026, whereas Net Loss is likely to drop (89.5 M) in 2026.

Open Interest Against 2026-04-17 Xeris Option Contracts

Although open interest is a measure utilized in the options markets, it could be used to forecast Xeris Pharmaceuticals' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Xeris Pharmaceuticals' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Xeris Pharmaceuticals stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Xeris Pharmaceuticals' open interest, investors have to compare it to Xeris Pharmaceuticals' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Xeris Pharmaceuticals is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Xeris. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.

Xeris Pharmaceuticals Additional Predictive Modules

Most predictive techniques to examine Xeris price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Xeris using various technical indicators. When you analyze Xeris charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
Forecasting cash, or other financial indicators, requires analysts to apply different statistical methods, techniques, and algorithms to find hidden patterns within the Xeris Pharmaceuticals' financial statements to predict how it will affect future prices.
 
Cash  
First Reported
2016-12-31
Previous Quarter
59.3 M
Current Value
91.6 M
Quarterly Volatility
30 M
 
Covid
A naive forecasting model for Xeris Pharmaceuticals is a special case of the moving average forecasting where the number of periods used for smoothing is one. Therefore, the forecast of Xeris Pharmaceuticals value for a given trading day is simply the observed value for the previous period. Due to the simplistic nature of the naive forecasting model, it can only be used to forecast up to one period.

Xeris Pharmaceuticals Naive Prediction Price Forecast For the 23rd of January

Given 90 days horizon, the Naive Prediction forecasted value of Xeris Pharmaceuticals on the next trading day is expected to be 7.96 with a mean absolute deviation of 0.28, mean absolute percentage error of 0.14, and the sum of the absolute errors of 17.07.
Please note that although there have been many attempts to predict Xeris Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Xeris Pharmaceuticals' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Xeris Pharmaceuticals Stock Forecast Pattern

Backtest Xeris PharmaceuticalsXeris Pharmaceuticals Price PredictionBuy or Sell Advice 

Xeris Pharmaceuticals Forecasted Value

In the context of forecasting Xeris Pharmaceuticals' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Xeris Pharmaceuticals' downside and upside margins for the forecasting period are 3.69 and 12.23, respectively. We have considered Xeris Pharmaceuticals' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
7.61
7.96
Expected Value
12.23
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Xeris Pharmaceuticals stock data series using in forecasting. Note that when a statistical model is used to represent Xeris Pharmaceuticals stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria116.1563
BiasArithmetic mean of the errors None
MADMean absolute deviation0.2799
MAPEMean absolute percentage error0.0355
SAESum of the absolute errors17.0718
This model is not at all useful as a medium-long range forecasting tool of Xeris Pharmaceuticals. This model is simplistic and is included partly for completeness and partly because of its simplicity. It is unlikely that you'll want to use this model directly to predict Xeris Pharmaceuticals. Instead, consider using either the moving average model or the more general weighted moving average model with a higher (i.e., greater than 1) number of periods, and possibly a different set of weights.

Predictive Modules for Xeris Pharmaceuticals

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Xeris Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
3.307.6111.92
Details
Intrinsic
Valuation
LowRealHigh
5.219.5213.83
Details
6 Analysts
Consensus
LowTargetHigh
10.1411.1412.37
Details
Earnings
Estimates (0)
LowProjected EPSHigh
0.010.010.01
Details

Other Forecasting Options for Xeris Pharmaceuticals

For every potential investor in Xeris, whether a beginner or expert, Xeris Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Xeris Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Xeris. Basic forecasting techniques help filter out the noise by identifying Xeris Pharmaceuticals' price trends.

Xeris Pharmaceuticals Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Xeris Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Xeris Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Xeris Pharmaceuticals by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Xeris Pharmaceuticals Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Xeris Pharmaceuticals' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Xeris Pharmaceuticals' current price.

Xeris Pharmaceuticals Market Strength Events

Market strength indicators help investors to evaluate how Xeris Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Xeris Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Xeris Pharmaceuticals stock market strength indicators, traders can identify Xeris Pharmaceuticals entry and exit signals to maximize returns.

Xeris Pharmaceuticals Risk Indicators

The analysis of Xeris Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Xeris Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting xeris stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Xeris Stock Analysis

When running Xeris Pharmaceuticals' price analysis, check to measure Xeris Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Xeris Pharmaceuticals is operating at the current time. Most of Xeris Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Xeris Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Xeris Pharmaceuticals' price. Additionally, you may evaluate how the addition of Xeris Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.